News
 
October 1, 2010
For Immediate Release

Contact: Julia Ahmet
(973) 463-9600 ext. 303


Community Hope To Honor Leaders from DRS Technologies and Lilly

Sparkle of Hope Charity Event on October 28th to Benefit Homeless Veterans and Individuals in Recovery from Mental Illness


PARSIPPANY, NJ -- Community Hope will host its Annual Sparkle of Hope Dinner Auction on Thursday, October 28, 2010 at 6 p.m. at the Birchwood Manor in Whippany, New Jersey. The annual charity event benefits Community Hope’s residential programs for hundreds of young adults and individuals in recovery from mental illness and substance abuse, including the nationally-acclaimed Hope for Veterans Program for homeless veterans.

More than 400 guests are expected to attend to honor Richard M. Goldberg, President of DRS Technologies Charitable Foundation and Senior Vice President of Public Affairs and Communications headquartered in Parsippany NJ, for his support of our veterans and John H. Johnson, President, Lilly Oncology and Senior Vice President, Eli Lilly and Company, for his contributions to advancing pharmaceutical treatments for serious and chronic diseases.

The Sparkle of Hope Dinner was founded in 1997 by Fred Hassan, Chairman of Bausch + Lomb. "The $4.6 million raised from this event since its inception has had a tremendous impact on the lives of hundreds of individuals suffering from mental illnesses and their families. The money raised through the Sparkle of Hope enables Community Hope to deliver essential housing and support services for 300 individuals each day. These funds also provide the resources for innovative new programs to reach more homeless veterans and young adults affected by mental illness,” said Hassan. "I'm pleased that Community Hope has raised more than $350,000 for this year's event so far and I encourage companies and individuals to support this important cause."

Co-Chairing the 2010 gala with Mr. Hassan are Dr. Sol Barer, Executive Chairman of the Celgene Corporation; John Crowley, President and CEO of Amicus Therapeutics; David Norton, Company Group Chairman of Global Pharmaceuticals for Johnson & Johnson; Dr. Stuart Peltz, President and CEO of PTC Therapeutics Inc.; Cavan Redmond, Senior Vice President, Pfizer Inc, and Group President, Pfizer Diversified Businesses; and Kevin Rigby, Vice President of Public Affairs and Communications for Novartis Pharmaceuticals Corporation.

Mr. Goldberg is being honored for his support of Community Hope’s Hope for Veterans Program, which provides housing and support services to 95 formerly homeless veterans daily. The DRS Technologies Charitable Foundation has provided more than $100,000 in funding for the Hope for Veterans Program since 2003 and has been an essential partner in the development and ongoing operations of the nationally-acclaimed program. Since 2006, the Foundation has raised and contributed over $5 million to charities, specifically those supporting veterans and their families

Mr. Goldberg joined DRS Technologies in 2005 as Vice President of Public Affairs and was promoted to Senior Vice President, Public Affairs and Communications, in 2009. Prior to joining DRS, he served as President of the Commerce and Industry Association of New Jersey (CIANJ), and publisher of the monthly magazine, COMMERCE. Previously, he was the Executive Director of the American Electronics Association (AeA). He serves on numerous boards, including the National Guard Education Foundation.

Mr. Johnson is being recognized for his 28-year career of advancing pharmaceutical treatments for serious and chronic diseases, ranging from mental illness to cancer. He was appointed President, Lilly Oncology and Senior Vice President of Lilly in 2009. Prior to this appointment, he had served as Chief Executive Officer of ImClone Systems since 2007 and was a member of ImClone’s board of directors until the company became a wholly-owned subsidiary of Lilly in 2008. Prior to joining ImClone, Mr. Johnson had served as Company Group Chairman of Johnson & Johnson’s Worldwide Biopharmaceuticals unit since 2005. He began his healthcare career with Pfizer in 1983, where he held positions of increasing responsibility in sales and sales management, until he joined Johnson & Johnson in 1988. Mr. Johnson advanced through positions of increasing responsibility with Ortho-McNeil, including leading the commercial groups responsible for the development of sales, marketing and new product strategies of several of the company’s flagship brands. He was appointed President of Ortho Biotech Products in March 2003 and held this position until being named Company Group Chairman in 2005.

Lead sponsors and underwriters of the charity event include the Celgene Corporation; DRS Technologies; Goldman, Sachs & Co.; the Johnson & Johnson Family of Companies; Lowenstein Sandler PC; Merck & Co.; and Pfizer Inc.

Gala activities include a raffle drawing for vacation packages; a 50/50 cash raffle and a silent auction featuring original artwork and autographed sports memorabilia. In addition, guests can participate in a raffle for chances to win nearly fifty other prizes.

Table prices range from $5,000 to $25,000. Individual tickets can be purchased for $140 per person. To purchase tables and tickets online and for more information on the Sparkle of Hope Dinner Auction, visit the events section of Community Hope’s website at www.communityhope-nj.org or call the Development Office at (973) 463-9600, extension 308.

Back